retatrutide clinical study ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide Reduces Body Weight by
Description
Its multi-action mechanism ensures that weight loss is both practical and sustainable
Diabetes Care, 48(7), e93
Require in-person clinical supervision: All MadeMed consultations are conducted through a secure online platform, not in-person visits
Wang F, Knutson K, Alcaino C
